The diagnosis of prostate cancer is complex, as PSA can be elevated in benign conditions, such as prostatitis, or benign prostatic hyperplasia (BPH), where there is a risk of false positive interpretation, while some aggressive tumors may present with PSA levels within the normal range, and thus being under-diagnosed (4). This evidence concerns the gene KLK3 and prostate carcinoma.